Dexmedetomidine-Induced Contraction in the Isolated Endothelium-Denuded Rat Aorta Involves PKC-dmediated JNK Phosphorylation

被引:9
作者
Yu, Jongsun [1 ,2 ]
Ok, Seong-Ho [1 ,2 ]
Kim, Won Ho [3 ]
Cho, Hyunhoo [4 ]
Park, Jungchul [4 ]
Shin, Il-Woo [1 ,2 ]
Lee, Heon Keun [1 ,2 ]
Chung, Young-Kyun [1 ,2 ]
Choi, Mun-Jeoung [5 ]
Kwon, Seong-Chun [6 ]
Sohn, Ju-Tae [1 ,2 ,7 ]
机构
[1] Gyeongsang Natl Univ, Sch Med, Dept Anesthesiol & Pain Med, Jinju Si 52727, South Korea
[2] Gyeongsang Natl Univ Hosp, Jinju Si 52727, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Dept Anesthesiol & Pain Med, Chang Won, South Korea
[4] Gyeongsang Natl Univ Hosp, Dept Anesthesiol & Pain Med, Jinju, South Korea
[5] Gyeongsang Natl Univ Hosp, Dept Oral & Maxillofacial Surg, Jinju, South Korea
[6] Catholic Kwandong Univ, Coll Med, Inst Clin & Translat Res, Dept Physiol, Kangnung 25601, South Korea
[7] Gyeongsang Natl Univ, Inst Hlth Sci, Jinju, South Korea
基金
新加坡国家研究基金会;
关键词
dexmedetomidine; protein kinase C; aorta; protein kinase C-delta; vasoconstriction; c-Jun NH2-terminal kinase; PROTEIN-KINASE-C; SMOOTH-MUSCLE-CELLS; CORONARY HEMODYNAMICS; ACTIVATION; HYPERTENSION; AGONIST; VASOCONSTRICTION; COMPLICATIONS; MEDETOMIDINE; SEDATION;
D O I
10.7150/ijms.11952
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vasoconstriction mediated by the highly selective alpha-2 adrenoceptor agonist dexmedetomidine leads to transiently increased blood pressure and severe hypertension. The dexmedetomidine-induced contraction involves the protein kinase C (PKC)-mediated pathway. However, the main PKC isoform involved in the dexmedetomidine-induced contraction remains unknown. The goal of this in vitro study was to examine the specific PKC isoform that contributes to the dexmedetomidine-induced contraction in the isolated rat aorta. The endothelium-denuded rat aorta was suspended for isometric tension recording. Dexmedetomidine dose-response curves were generated in the presence or absence of the following inhibitors: the pan-PKC inhibitor, chelerythrine; the PKC-alpha and -beta inhibitor, Go6976; the PKC-alpha inhibitor, safingol; the PKC-beta inhibitor, ruboxistaurin; the PKC-delta inhibitor, rottlerin; the c-Jun NH2-terminal kinase (JNK) inhibitor, SP600125; and the myosin light chain kinase inhibitor, ML-7 hydrochloride. Western blot analysis was used to examine the effect of rottlerin on dexmedetomidine-induced PKC-delta expression and JNK phosphorylation in rat aortic vascular smooth muscle cells (VSMCs) and to investigate the effect of dexmedetomidine on PKC-delta expression in VSMCs transfected with PKC-delta small interfering RNA (siRNA) or control siRNA. Chelerythrine as well as SP600125 and ML-7 hydrochloride attenuated the dexmedetomidine-induced contraction. Go6976, safingol, and ruboxistaurin had no effect on the dexmedetomidine-induced contraction, whereas rottlerin inhibited the dexmedetomidine-induced contraction. Dexmedetomidine induced PKC-delta expression, whereas rottlerin and PKC-delta siRNA transfection inhibited dexmedetomidine-induced PKC-delta expression. Dexmedetomidine also induced JNK phosphorylation, which was inhibited by rottlerin. Taken together, these results suggest that the dexmedetomidine-induced contraction involves PKC-delta-dependent JNK phosphorylation in the isolated rat aorta.
引用
收藏
页码:727 / 736
页数:10
相关论文
共 34 条
[1]   Cellular and molecular mechanisms regulating vascular tone.: Part 2:: regulatory mechanisms modulating Ca2+ mobilization and/or myofilament Ca2+ sensitivity in vascular smooth muscle cells [J].
Akata, Takashi .
JOURNAL OF ANESTHESIA, 2007, 21 (02) :232-242
[2]   Eucapnic intermittent hypoxia augments endothelin-1 vasoconstriction in rats:: role of PKCδ [J].
Allahdadi, Kyan J. ;
Duling, Laura C. ;
Walker, Benjimen R. ;
Kanagy, Nancy L. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2008, 294 (02) :H920-H927
[3]   Dexmedetomidine-induced Contraction Involves Phosphorylation of Caldesmon by JNK in Endothelium-denuded Rat Aortas [J].
Baik, Jiseok ;
Ok, Seong-Ho ;
Cho, Hyunhoo ;
Yu, Jongsun ;
Kim, Woochan ;
Nam, In-Koo ;
Choi, Mun-Jeoung ;
Lee, Heon-Keun ;
Sohn, Ju-Tae .
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2014, 10 (10) :1108-1115
[4]   EFFECTS OF INTRAVENOUS DEXMEDETOMIDINE IN HUMANS .2. HEMODYNAMIC-CHANGES [J].
BLOOR, BC ;
WARD, DS ;
BELLEVILLE, JP ;
MAZE, M .
ANESTHESIOLOGY, 1992, 77 (06) :1134-1142
[5]   Location of resistance arteries [J].
Christensen, KL ;
Mulvany, MJ .
JOURNAL OF VASCULAR RESEARCH, 2001, 38 (01) :1-12
[6]   The role of protein kinase C activation and the vascular complications of diabetes [J].
Das Evcimen, Net ;
King, George L. .
PHARMACOLOGICAL RESEARCH, 2007, 55 (06) :498-510
[7]   Therapeutic Potential for Protein Kinase C Inhibitor in Vascular Restenosis [J].
Ding, Richard Qinxue ;
Tsao, Jerry ;
Chai, Hong ;
Mochly-Rosen, Daria ;
Zhou, Wei .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2011, 16 (02) :160-167
[8]   High-dose Dexmedetomidine-induced Hypertension in a Child with Traumatic Brain Injury [J].
Erkonen, Gwen ;
Lamb, Fred ;
Tobias, Joseph D. .
NEUROCRITICAL CARE, 2008, 9 (03) :366-369
[9]   IL-1β enhances vascular smooth muscle cell proliferation and migration via P2Y2 receptor-mediated RAGE expression and HMGB1 release [J].
Eun, So Young ;
Ko, Young Shin ;
Park, Sang Won ;
Chang, Ki Churl ;
Kim, Hye Jung .
VASCULAR PHARMACOLOGY, 2015, 72 :108-117
[10]  
Flacke W E, 1993, J Cardiothorac Vasc Anesth, V7, P41, DOI 10.1016/1053-0770(93)90117-4